Elanco Animal Health (ELAN)
(Delayed Data from NYSE)
$15.35 USD
+0.33 (2.20%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $15.36 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Income Statements
Fiscal Year end for Elanco Animal Health Incorporated falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 4,417 | 4,411 | 4,765 | 3,273 | 3,071 |
Cost Of Goods | 1,931 | 1,913 | 2,134 | 1,667 | 1,470 |
Gross Profit | 2,486 | 2,498 | 2,631 | 1,607 | 1,601 |
Selling & Adminstrative & Depr. & Amort Expenses | 3,329 | 2,297 | 2,957 | 2,307 | 1,416 |
Income After Depreciation & Amortization | -843 | 201 | -326 | -701 | 185 |
Non-Operating Income | -75 | -32 | -5 | 178 | -27 |
Interest Expense | 277 | 241 | 236 | 150 | 79 |
Pretax Income | -1,195 | -72 | -567 | -672 | 78 |
Income Taxes | 36 | 6 | -95 | -112 | 10 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -1,231 | -78 | -472 | -560 | 68 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -1,231 | -78 | -472 | -560 | 68 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -149 | 883 | 390 | -184 | 499 |
Depreciation & Amortization (Cash Flow) | 694 | 682 | 716 | 517 | 315 |
Income After Depreciation & Amortization | -843 | 201 | -326 | -701 | 185 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 492.30 | 488.30 | 487.20 | 441.40 | 370.30 |
Diluted EPS Before Non-Recurring Items | 0.89 | 1.11 | 1.05 | 0.47 | 1.06 |
Diluted Net EPS (GAAP) | -2.50 | -0.16 | -0.97 | -1.27 | 0.18 |
Fiscal Year end for Elanco Animal Health Incorporated falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1,184.00 | 1,205.00 | 1,035.00 | 1,068.00 | 1,057.00 |
Cost Of Goods | 495.00 | 515.00 | 516.00 | 487.00 | 434.00 |
Gross Profit | 689.00 | 690.00 | 519.00 | 581.00 | 623.00 |
SG&A, R&D, and Dept/Amort Expenses | 654.00 | 603.00 | 545.00 | 1,597.00 | 605.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 35.00 | 87.00 | -26.00 | -1,016.00 | 18.00 |
Non-Operating Income | -2.00 | -9.00 | -34.00 | -9.00 | -23.00 |
Interest Expense | 65.00 | 66.00 | 67.00 | 72.00 | 74.00 |
Pretax Income | -32.00 | 12.00 | -127.00 | -1,097.00 | -79.00 |
Income Taxes | 18.00 | -20.00 | 14.00 | -1.00 | 18.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -50.00 | 32.00 | -141.00 | -1,096.00 | -97.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -50.00 | 32.00 | -141.00 | -1,096.00 | -97.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 494.20 | 496.00 | 492.80 | 492.70 | 492.60 |
Diluted EPS Before Non-Recurring Items | 0.30 | 0.34 | 0.08 | 0.18 | 0.18 |
Diluted Net EPS (GAAP) | -0.10 | 0.06 | -0.29 | -2.22 | -0.20 |